Medicinal Cannabis is cannabis that is grown and sold pursuant to the Medicinal Cannabis Industry Act, 2019 that includes the seeds, immature plants as well as all parts of the plant, along with resin extracted from any part of the plant, every compound, manufacture, salt, derivative, mixture or preparation from cannabis; or cannabis concentrate; that is cultivated, processed, manufactured, distributed or sold under a licence from the BMCLA. As a medicine, it is prescribed and recommended by physicians to provide a therapeutic effect.

There is really no difference between the terms of adult use and recreational use of cannabis. However, the term “adult-use” while is for better optics, it comes from the notion that not all consumers of cannabis are consuming solely for recreational purposes. Cannabis can and is utilized for many reasons that go beyond the recreational/ medicinal cannabis binary.

Recreational cannabis primarily uses THC (tetrahydrocannabinol), a psychoactive agent that is responsible for the ‘high’ that comes from the consumption of cannabis via inhalation by smoking/vaping recreationally or oral administration.

Cannabis means all parts of any plant of the genus cannabis including any resin obtained from the plant.

The Barbados Medicinal Cannabis Licensing Authority (BMCLA) is the sole regulator, that is mandated to create and position the local medicinal cannabis industry as a global centre of excellence in training, certification, research and development and to provide a high quality, accessible and advanced patient-centric environment to qualifying individuals.

The BMCLA also ensures that the safety of the public and consumers of medicinal cannabis and its by-products are adequately protected, by appropriately regulating the importation, sale, distribution, possession, purchase, manufacture, cultivation, transportation and exportation of medicinal cannabis.